FDA Inspection 1012258 — American Red Cross Biomedical Services IRB

American Red Cross Biomedical Services IRB — FEI 3005118166

The FDA completed an inspection of American Red Cross Biomedical Services IRB on May 24, 2017 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Rockville, MD (United States)

Additional Details

IRB